Ifp Advisors, Inc Celularity Inc Transaction History

Ifp Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 30, 2024	BUY	$0.19 - $6.96 $1,900 - $69,600	10,000 New	10,000 $52,000
Q2 2023 Aug 04, 2023	BUY	$0.42 - $0.81 $2,100 - $4,050	5,000 New	5,000 $2,000
Q4 2022 Feb 07, 2023	SELL	$1.08 - $2.35 $3,780 - $8,225	-3,500 Reduced 36.84%	6,000 $73,000
Q3 2022 Nov 08, 2022	BUY	$0.43 - $4.31 $1,720 - $17,240	4,000 Added 72.73%	9,500 $114,000
Q2 2022 Sep 06, 2022	BUY	$2.81 - $12.91 $15,455 - $71,005	5,500 New	5,500 $67,000
Q2 2022 Aug 12, 2022	SELL	$2.81 - $12.91 $15,455 - $71,005	-5,500 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$3.81 - $9.79 $20,955 - $53,844	5,500 New	5,500 $47,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.